Guidance documents

Collaboration between clinical trials units (CTUs), working in partnership with clinical investigators (CIs), and pharmaceutical company partners is a key aspect of UK clinical cancer research and has been a key contributor to the growth of clinical trial activity in cancer over the past decade. In order to expedite successful partnerships a consistent approach to collaboration is required.

The NCRI Cancer CTU Group have developed two sets of guidelines to aid these collaborations, Principles for collaboration with pharmaceutical company partners and Reasonable access to and sharing of trial data with pharmaceutical company partners

» Download the Principles for collaboration guidance here (PDF)

» Download the Reasonable sharing of trial data guidance here (PDF)

uk map with pointers

Manchester Academic Health Sciences Centre Trials Unit (MAHSC-CTU)
Liverpool Cancer Research UK Clinical Trials Unit (LCTU), Liverpool
Cancer Research UK Clinical Trials Unit (CRCTU), Birmingham
Warwick Clinical Trials Unit
Wales Cancer Trials Unit (WCTU), Cardiff
Bristol Randomised Trials Collaboration (BRTC)
Oxford Clinical Trials Research Unit (OCTRU)
Southampton Clinical Trials Unit
Institute of Cancer Research Clinical Trials and Statistics Unit (ICR-CTSU), Sutton
Cancer Prevention Trials Unit at Barts CTU, London
Medical Research Council Clinical Trials Unit (MRC CTU at UCL), London
Cancer Research UK & University College London Cancer Trials Centre (CRUK & UCL CTC), London
Cambridge Clinical Trials Unit, Cambridge
Clinical Trials Research Unit (CTRU), Leeds
Cancer Clinical Trials Unit Scotland (CaCTUS), Edinburgh
Cancer Clinical Trials Unit Scotland (CaCTUS), Glasgow

Click on a CTU to display more information.